Infinity Pharmaceuticals Inc (NASDAQ:INFI)

2.16
Delayed Data
As of Apr 25
 -0.04 / -1.82%
Today’s Change
0.93
Today|||52-Week Range
3.75
+6.40%
Year-to-Date

Today’s Trading

Previous close2.20
Today’s open2.18
Day’s range2.14 - 2.21
Volume213,319
Average volume (3 months)799,273
Market cap$129.3M
Data as of 4:00pm ET, 04/25/2018

Growth & Valuation

Earnings growth (last year)+76.72%
Earnings growth (this year)--
Earnings growth (next 5 years)+101.00%
Revenue growth (last year)-82.83%
P/E ratioNM
Price/Sales3.58
Price/Book1.56

Competitors

 Today’s
change
Today’s
% change
ATNMActinium Pharmaceuti...+0.00+0.20%
GNMXAevi Genomic Medicin...+0.04+2.63%
JNPJuniper Pharmaceutic...-0.05-0.62%
SNSSSunesis Pharmaceutic...+0.04+1.44%
Data as of 4:00pm ET, 04/25/2018

Financials

Next reporting dateMay 8, 2018
EPS forecast (this quarter)-$0.52
Annual revenue (last year)$18.7M
Annual profit (last year)-$30.1M
Net profit margin-160.77%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Adelene Q. Perkins
President &
Treasurer
Lawrence E. Bloch
Corporate headquarters
Cambridge, Massachusetts

Forecasts